Genelux

Genelux

Developed a robust drug discovery capability, building a pipeline of innovative oncolytic virus-based cancer therapies and collaborates with leading medical and academic research institutions.

Launch date
Employees
Market cap
€76.6m
Enterprise valuation
€48m (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...